Found 6 matching trials
Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease PHASE2 The purpose of this study is to characterize the safety, efficacy and dose ...
Show More Location
University Of California, San Diego
Learn More & Join Trial
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) PHASE2 This is a two-part, phase 2b and phase 3 combined prospective, intervention...
Show More Location
Nephrology of North Alabama
Learn More & Join Trial
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study PHASE2 The primary objective of this study is to evaluate several interventions gi...
Show More Location
Mayo Clinic Scottsdale
Learn More & Join Trial
A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD) PHASE1 This is a phase 1b, partial-blind (Sponsor unblinded), randomized, multicen...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy PHASE2 The purpose of this study is to characterize the safety, efficacy and dose ...
Show More Location
San Diego Arthritis Medical Clinic
Learn More & Join Trial
Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis PHASE2 The primary purpose of this study is to identify an appropriate dose of stu...
Show More Location
Rheumatology Associates Of North Alabama, P.C.
Learn More & Join Trial